Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MME | P08473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16012060 | 0.84 | CA1 (0.34) | CA1CA9TSHRALDH1A1 | |
| SCHEMBL5870408 | 0.80 | ALDH1A1 (0.42) | TSHRMMEALDH1A1 | |
| SCHEMBL8507193 | 0.80 | ALDH1A1 (0.42) | TSHRMMEALDH1A1 | |
| SCHEMBL299523 | 0.80 | ALDH1A1 (0.42) | TSHRMMEALDH1A1 | |
| SCHEMBL8625060 | 0.78 | CA1 (0.37) | CA1CA9TSHRALDH1A1 | |
| SCHEMBL2166841 | 0.74 | CYP1A2 (0.41) | CA1CA9TSHRALDH1A1 | |
| SCHEMBL28762173 | 0.74 | TSHR (0.36) | CA1CA9TSHRALDH1A1 | |
| SCHEMBL19746245 | 0.73 | ALDH1A1 (0.38) | TSHRMMEALDH1A1 | |
| SCHEMBL2690043 | 0.73 | — | — | |
| SCHEMBL13201835 | 0.72 | KCNH3 (0.34) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017019791-A1 | SYNTHESIS OF (S)-PREGABALIN | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2017-02-02 | — | — | WO | claimed |
| EP-3046970-B1 | LAUNDRY CARE COMPOSITIONS CONTAINING THIOPHENE AZO CARBOXYLATE DYES | MILLIKEN & CO (US) | 2018-11-07 | — | — | EP | disclosed |
| US-20180134995-A1 | Laundry Care Compositions Containing Dyes | MILLIKEN & COMPANY | 2018-05-17 | — | — | US | disclosed |
| EP-3047010-B1 | LAUNDRY CARE COMPOSITIONS CONTAINING THIOPHENE AZO CARBOXYLATE DYES | PROCTER & GAMBLE (US) | 2018-05-09 | — | — | EP | disclosed |
| US-20170137629-A1 | Laundry Care Compositions Containing Dyes | MILLIKEN & COMPANY | 2017-05-18 | — | — | US | disclosed |
| WO-2017019791-A1 | SYNTHESIS OF (S)-PREGABALIN | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2017-02-02 | — | — | WO | disclosed |
| US-20160257912-A1 | LAUNDRY CARE COMPOSITIONS CONTAINING DYES | PROCTER & GAMBLE (US) | 2016-09-08 | — | — | US | disclosed |
| EP-3046970-A1 | LAUNDRY CARE COMPOSITIONS CONTAINING THIOPHENE AZO CARBOXYLATE DYES | Milliken & Company (US) | 2016-07-27 | — | — | EP | disclosed |
| EP-3047010-A1 | LAUNDRY CARE COMPOSITIONS CONTAINING THIOPHENE AZO CARBOXYLATE DYES | The Procter & Gamble Company (US) | 2016-07-27 | — | — | EP | disclosed |
| US-9371507-B2 | Laundry care compositions containing dyes | THE PROCTER & GAMBLE COMPANY (US) | 2016-06-21 | — | — | US | disclosed |
| US-5886024-A | ENZYME INHIBITOR FOR TREATING ARTHRITIS, RHEUMATOID ARTHRITIS, SEPTIC ARTHRITIS, PERIODONTAL DISEASE, CORNEAL ULCERATION, PROTEINURIA, ANEURYSMAL AORTIC DISEASE, DYSTROPHOBIC EPIDERMOLYSIS BULLOSA | BAYER CORPORATION (US) | 1999-03-23 | — | — | US | disclosed |
| US-5886022-A | TREATMENT OF OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, SEPTIC ARTHRITIS, PERIODONTAL DISEASE, CORNEAL ULCERATION, PROTEINURIA, ANEURYSMAL AORTIC DISEASE, DYSTROPHOBIC EPIDERMOLYSIS BULLOSA | BAYER CORPORATION (US) | 1999-03-23 | — | — | US | disclosed |
| US-5874473-A | OSTEOPOROSIS; ANTIARTHRITIC AGENTS | BAYER CORPORATION (US) | 1999-02-23 | — | — | US | disclosed |
| US-5861428-A | ALLEVIATION OF OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, SEPTIC ARTHRITIS, PERIODONTAL DISEASE, CORNEAL ULCERATION, PROTEINURIA, ANEURYSMAL AORTIC DISEASE, DYSTROPHOBIC EPIDERMOLYSIS BULLOSA, INFLAMMATION, OSTEOPENIAS, TEMPERO | BAYER CORPORATION (US) | 1999-01-19 | — | — | US | disclosed |
| US-5861427-A | ALLEVIATION OF OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, SEPTIC ARTHRITIS, PERIODONTAL DISEASE, CORNEAL ULCERATION, PROTEINURIA, ANEURYSMAL AORTIC DISEASE, DYSTROPHOBIC EPIDERMOLYSIS BULLOSA, CONDITIONS LEADING TO INFLAMMATORY | BAYER HEALTHCARE LLC | 1999-01-19 | — | — | US | disclosed |
| US-5859047-A | ANTIARTHRITIC AGENTS, NERVOUS SYSTEM DISORDERS | BAYER CORPORATION (US) | 1999-01-12 | — | — | US | disclosed |
| US-5854277-A | Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors | BAYER CORPORATION (US) | 1998-12-29 | — | — | US | disclosed |
| US-5789434-A | ACID, ESTER OR AMIDE DERIVATIVES AS ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS AND REDUCTION OF CARTILAGE DETERIORATION | BAYER CORPORATION (US) | 1998-08-04 | — | — | US | disclosed |
| EP-0790974-A1 | SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS | Bayer Corporation (US) | 1997-08-27 | — | — | EP | disclosed |
| WO-1996015096-A1 | SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS | BAYER CORPORATION (US) | 1996-05-23 | — | — | WO | disclosed |